• OPEN AN ACCOUNT
Indian Indices
Sensex
77,540.83 3.11
( 0.00%)
Global Indices
Nasdaq
53,294.39 514.18
(0.97%)
Dow Jones
7,693.51 31.35
(0.41%)
Hang Seng
65,893.13 -323.66
(-0.49%)
Nikkei 225
10,809.01 60.85
(0.57%)
Forex
USD-INR
95.67 0.05
(0.05%)
EUR-INR
111.76 0.57
(0.51%)
GBP-INR
130.35 0.55
(0.42%)
JPY-INR
0.60 0.00
(0.11%)

EQUITY - MARKET SCREENER

Marksans Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524404
INE750C01026
36.4616629
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MARKSANS
45.25
14557.89
EPS(TTM)
Face Value()
Div & Yield %
7.1
1
0.28
 

Hardwyn India consolidated net profit rises 84.41% in the March 2026 quarter
Jun 01,2026
Net profit of Hardwyn India rose 84.41% to Rs 3.43 crore in the quarter ended March 2026 as against Rs 1.86 crore during the previous quarter ended March 2025. Sales rose 25.22% to Rs 57.15 crore in the quarter ended March 2026 as against Rs 45.64 crore during the previous quarter ended March 2025.

For the full year,net profit rose 17.63% to Rs 13.21 crore in the year ended March 2026 as against Rs 11.23 crore during the previous year ended March 2025. Sales rose 8.27% to Rs 199.86 crore in the year ended March 2026 as against Rs 184.60 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales57.1545.64 25 199.86184.60 8
OPM %10.016.53 -10.619.77 -
PBDT5.553.08 80 20.6517.61 17
PBT5.042.63 92 18.8115.85 19
NP3.431.86 84 13.2111.23 18